NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

BaboA.00781.a: acetyl-CoA acetyltransferase, putative

Target Characteristics

from organism: Babesia bovis T2Bo
most recent status: cloned
center reference id: BaboA.00781.a
is community request: True
associated disease: Babesiosis (atypical)
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
I

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

External Resources

Resource Reference ID
EuPathDB: PiroplasmaDB:BBOV_I002980
OrthoMCL: OG5_126757
RefSeq: XP_001608948.1
UniProt: A7AWF2

Enzyme & Pathway Information

Pathway Pathway ID EC Number
acetoacetate degradation (to acetyl CoA) ACETOACETATE-DEG-PWY 2.3.1.9
pyruvate fermentation to butanoate CENTFERM-PWY 2.3.1.9
superpathway of ergosterol biosynthesis I ERGOSTEROL-SYN-PWY 2.3.1.9
L-glutamate degradation VII (to butanoate) GLUDEG-II-PWY 2.3.1.9
L-isoleucine degradation I ILEUDEG-PWY 2.3.1.9
L-glutamate degradation V (via hydroxyglutarate) P162-PWY 2.3.1.9
L-lysine fermentation to acetate and butanoate P163-PWY 2.3.1.9
polyhydroxybutanoate biosynthesis PWY1-3 2.3.1.9
fermentation to 2-methylbutanoate PWY-5109 2.3.1.9
glutaryl-CoA degradation PWY-5177 2.3.1.9
toluene degradation VI (anaerobic) PWY-5184 2.3.1.9
superpathway of L-lysine degradation PWY-5327 2.3.1.9
acetyl-CoA fermentation to butanoate II PWY-5676 2.3.1.9
ethylmalonyl-CoA pathway PWY-5741 2.3.1.9
3-hydroxypropanoate/4-hydroxybutanate cycle PWY-5789 2.3.1.9
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) PWY-5910 2.3.1.9
Methanobacterium thermoautotrophicum biosynthetic metabolism PWY-6146 2.3.1.9
mevalonate pathway II (archaea) PWY-6174 2.3.1.9
pyruvate fermentation to butanol I PWY-6583 2.3.1.9
pyruvate fermentation to acetone PWY-6588 2.3.1.9
superpathway of Clostridium acetobutylicum acidogenic fermentation PWY-6590 2.3.1.9
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 2.3.1.9
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 2.3.1.9
ketogenesis PWY66-367 2.3.1.9
ketolysis PWY66-368 2.3.1.9
superpathway of cholesterol biosynthesis PWY66-5 2.3.1.9
pyruvate fermentation to hexanol (engineered) PWY-6863 2.3.1.9
isopropanol biosynthesis (engineered) PWY-6876 2.3.1.9
pyruvate fermentation to butanol II (engineered) PWY-6883 2.3.1.9
1-butanol autotrophic biosynthesis (engineered) PWY-6886 2.3.1.9
glycerol degradation to butanol PWY-7003 2.3.1.9
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered) PWY-7216 2.3.1.9
photosynthetic 3-hydroxybutanoate biosynthesis (engineered) PWY-7218 2.3.1.9
isoprene biosynthesis II (engineered) PWY-7391 2.3.1.9
crotonate fermentation (to acetate and cyclohexane carboxylate) PWY-7401 2.3.1.9
benzoate fermentation (to acetate and cyclohexane carboxylate) PWY-7402 2.3.1.9
mevalonate pathway III (archaea) PWY-7524 2.3.1.9
2-methylpropene degradation PWY-7778 2.3.1.9
methyl tert-butyl ether degradation PWY-7779 2.3.1.9
4-oxopentanoate degradation PWY-7948 2.3.1.9
mevalonate pathway I PWY-922 2.3.1.9
L-tryptophan degradation III (eukaryotic) TRYPTOPHAN-DEGRADATION-1 2.3.1.9

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MANIIGFART PFVPILGAFA QESSTSLGIS AVKGAISKGI VNANAIDTLV LSQVITGGTG PSPSRQISKG AGLPNTTKCM QINHLCTSGL KSVTIATDGI ALGKSQLTAV VGVESSSQSP YLLTKAREGG YGLGDGVLVD PLTSDGFSSP CMDPDTFLKH VKITNAELSQ YVQEMFQQTA ACYSDGIMQN EIIPVVVNRK NNHKYGGLWI TPPQQKVSED ILPKLHNPKN LSGSIKTICT LADGAACLLL ANDDFVNRLG ISPYARILSY CEESVDGSQF PKALVGVIKK IIAEVNHRVD LYDIMDQYAL LSVYASRNLD IDHSRINTNG STIAIGHPMG ATGIRQTISL VTALRARQLR YGCVAGTNLS GDAIAMLIEV C

NT Sequence
atggcaaaca taattggctt tgcacgcacg ccattcgtcc ctattttggg tgcctttgca caggaatcta gcacttcact aggcatcagt gcagtcaaag gtgctatcag taaaggaatc gttaacgcaa atgcaatcga tacactagtg ctatcacaag ttattaccgg tgggactggt ccttcaccat ctaggcagat ttcaaaagga gctggccttc caaacacaac aaaatgtatg caaataaacc acttgtgcac ttctgggttg aaaagtgtta caattgctac tgatggaatc gcattgggca aatcgcaact cacggcagtg gtgggtgtgg aaagctcgtc gcagtcaccg tacctattaa caaaagcgag agagggtgga tatggactgg gtgatggtgt cctagtagac cccctaacca gtgacgggtt ttcctcgcct tgcatggatc ctgatacatt ccttaaacac gttaagataa caaacgcgga attgtcacaa tatgttcaag agatgtttca acaaacagct gcatgttaca gtgacggtat aatgcagaat gagataattc ctgtcgtggt gaatcgcaag aataatcaca agtatggcgg gttatggata actccgccac agcaaaaagt atcggaagat atactaccca aattgcacaa ccccaagaat ctttctggta gtataaaaac aatatgtacc ttggctgatg gtgctgcatg tttactactg gcaaatgacg atttcgtgaa tcggctgggt atatcaccat acgcacgtat acttagttac tgtgaagaga gtgtcgatgg gtctcagttt ccaaaggcac tggtcggcgt catcaagaag attattgccg aagtgaatca cagggtcgac ctatatgaca taatggatca gtatgctctc ttgtcggtat acgcatctag gaatctggat atagatcatt cccgtataaa cacaaatggc agcacgattg caatcgggca cccaatgggc gccactggaa tacgccagac aatatctttg gtaactgctt tacgagcacg tcaactacgc tacggctgcg tagctggtac caatctgtcg ggtgatgcga tagccatgct gatagaggtt tgctaa

© 2019 Center for Infectious Disease Research. All rights reserved. Contact ssgcid@cidresearch.org with questions or feedback.